J
James Spencer
Researcher at University of Bristol
Publications - 121
Citations - 8117
James Spencer is an academic researcher from University of Bristol. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 31, co-authored 105 publications receiving 6227 citations. Previous affiliations of James Spencer include Western University of Health Sciences.
Papers
More filters
Journal ArticleDOI
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study
Yiyun Liu,Yang Wang,Timothy R. Walsh,Ling-Xian Yi,Rong Zhang,James Spencer,Yohei Doi,Guo-Bao Tian,Baolei Dong,Xianhui Huang,Lin-Feng Yu,Danxia Gu,Hongwei Ren,Xiaojie Chen,Luchao Lv,Dandan He,Hongwei Zhou,Zi-sen Liang,Jian-Hua Liu,Jianzhong Shen +19 more
TL;DR: The emergence of MCR-1 heralds the breach of the last group of antibiotics, polymyxins, by plasmid-mediated resistance, in Enterobacteriaceae and emphasise the urgent need for coordinated global action in the fight against pan-drug-resistant Gram-negative bacteria.
Journal ArticleDOI
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Catherine L. Tooke,Philip Hinchliffe,Eilis C. Bragginton,Charlotte K. Colenso,Viivi H. A. Hirvonen,Yuiko Takebayashi,James Spencer +6 more
TL;DR: It is contended that issues including continuing unresolved questions around mechanism; opportunities afforded by new technologies such as serial femtosecond crystallography; the need for new inhibitors, particularly for MBLs; the likely impact of new β-lactam:inhibitor combinations and the continuing clinical importance of β- lactams mean that this remains a rewarding research area.
Journal ArticleDOI
An integrated kinetic analysis of intermediates and transition states in protein folding reactions
TL;DR: Relaxation rates for folding and unfolding of two proteins have been measured over a range of denaturant concentrations to examine the reaction pathways leading to the late transition state and results reveal the existence of a single intermediate.
Journal ArticleDOI
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
Jürgen Brem,Ricky Cain,Samuel T. Cahill,Michael A. McDonough,Ian J. Clifton,Juan-Carlos Jiménez-Castellanos,Matthew B. Avison,James Spencer,Colin W. G. Fishwick,Christopher J. Schofield +9 more
TL;DR: This article showed that cyclic boronates potently inhibit both nucleophilic serine and zinc-dependent β-lactamases by a mechanism involving mimicking of the common tetrahedral intermediate.
Journal ArticleDOI
UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes
Christopher G. V. Sharples,Sergio Kaiser,L. Soliakov,Michael J. Marks,Allan C. Collins,Mark S. Washburn,Emma Wright,James Spencer,Timothy Gallagher,Paul Whiteaker,Susan Wonnacott +10 more
TL;DR: The involvement of α4β2* nAChR in the presynaptic modulation of striatal dopamine release is supported and the utility of exploiting a novel partial agonist, together with a selective antagonist, to dissect the functional roles of nA ChR subtypes in the brain is illustrated.